AAAAAA
Results:
1-24
|
Results: 24
Authors:
Stadler, WM
Steinberg, G
Yang, XM
Hagos, F
Turner, C
Olopade, OI
Citation: Wm. Stadler et al., Alterations of the 9p21 and 9q33 chromosomal bands in clinical bladder cancer specimens by fluorescence in situ hybridization, CLIN CANC R, 7(6), 2001, pp. 1676-1682
Authors:
Rudin, CM
Holmlund, J
Fleming, GF
Mani, S
Stadler, WM
Schumm, P
Monia, BP
Johnston, JF
Geary, R
Yu, RZ
Kwoh, TJ
Dorr, FA
Ratain, MJ
Citation: Cm. Rudin et al., Phase I trial of ISIS 5132, an antisense oligonucleotide inhibitor of c-raf-1, administered by 24-hour weekly infusion to patients with advanced cancer, CLIN CANC R, 7(5), 2001, pp. 1214-1220
Authors:
Ratain, MJ
Stadler, WM
Citation: Mj. Ratain et Wm. Stadler, Clinical trial designs for cytostatic agents, J CL ONCOL, 19(12), 2001, pp. 3154-3154
Authors:
Cohen, EEW
Stadler, WM
Citation: Eew. Cohen et Wm. Stadler, Treatment of metastatic urothelial cancer in the post-MVAC era, WORLD J URO, 19(2), 2001, pp. 126-132
Authors:
Vogelzang, NJ
Aklilu, M
Stadler, WM
Dumas, MC
Mikulski, SM
Citation: Nj. Vogelzang et al., A phase II trial of weekly intravenous ranpirnase (Onconase (R)), a novel ribonuclease in patients with metastatic kidney cancer, INV NEW DR, 19(3), 2001, pp. 255-260
Authors:
Ryan, CW
Stadler, WM
Vogelzang, NJ
Citation: Cw. Ryan et al., Docetaxel and exisulind in hormone-refractory prostate cancer, SEMIN ONCOL, 28(4), 2001, pp. 56-61
Authors:
Rini, BI
Zimmerman, TM
Gajewski, TF
Stadler, WM
Vogelzang, NJ
Citation: Bi. Rini et al., Allogeneic peripheral blood stem cell transplantation for metastatic renalcell carcinoma, J UROL, 165(4), 2001, pp. 1208-1209
Authors:
Kim, HL
Vander Griend, DJ
Yang, XM
Benson, DA
Dubauskas, Z
Yoshida, BA
Chekmareva, MA
Ichikawa, Y
Sokoloff, MH
Zhan, P
Karrison, T
Lin, AN
Stadler, WM
Ichikawa, T
Rubin, MA
Rinker-Schaeffer, CW
Citation: Hl. Kim et al., Mitogen-activated protein kinase kinase 4 metastasis suppressor gene expression is inversely related to histological pattern in advancing human prostatic cancers, CANCER RES, 61(7), 2001, pp. 2833-2837
Authors:
Mani, S
Vogelzang, NJ
Bertucci, D
Stadler, WM
Schilsky, RL
Ratain, MJ
Citation: S. Mani et al., Phase I study to evaluate multiple regimens of intravenous 5-fluorouracil administered in combination with weekly gemcitabine in patients with advanced solid tumors - A potential broadly active regimen for advanced solid tumor malignancies, CANCER, 92(6), 2001, pp. 1567-1576
Authors:
Innocenti, F
Stadler, WM
Iyer, L
Ramirez, J
Vokes, EE
Ratain, MJ
Citation: F. Innocenti et al., Flavopiridol metabolism in cancer patients is associated with the occurrence of diarrhea, CLIN CANC R, 6(9), 2000, pp. 3400-3405
Authors:
Konety, BR
Nguyen, TST
Dhir, R
Day, RS
Becich, MJ
Stadler, WM
Getzenberg, RH
Citation: Br. Konety et al., Detection of bladder cancer using a novel nuclear matrix protein, BLCA-4, CLIN CANC R, 6(7), 2000, pp. 2618-2625
Authors:
Chien, M
Rinker-Schaeffer, C
Stadler, WM
Citation: M. Chien et al., A G2/M growth arrest response to low-dose intermittent H2O2 in normal uroepithelial cells, INT J ONCOL, 17(3), 2000, pp. 425-432
Authors:
Stadler, WM
Vogelzang, NJ
Amato, R
Sosman, J
Taber, D
Liebowitz, D
Vokes, EE
Citation: Wm. Stadler et al., Flavopiridol, a novel cyclin-dependent kinase inhibitor, in metastatic renal cancer: A University of Chicago phase II consortium study, J CL ONCOL, 18(2), 2000, pp. 371-375
Authors:
Rini, BI
Vogelzang, NJ
Dumas, MC
Wade, JL
Taber, DA
Stadler, WM
Citation: Bi. Rini et al., Phase II trial of weekly intravenous gemcitabine with continuous infusion fluorouracil in patients with metastatic renal cell cancer, J CL ONCOL, 18(12), 2000, pp. 2419-2426
Authors:
Goh, BC
Fleming, GF
Janisch, L
Vogelzang, NJ
Stadler, WM
Ratain, MJ
Citation: Bc. Goh et al., Development of a schedule-dependent population pharmacodynamic model for rhizoxin without quantitation of plasma concentrations, CANC CHEMOT, 45(6), 2000, pp. 489-494
Authors:
Stadler, WM
Ratain, MJ
Citation: Wm. Stadler et Mj. Ratain, Development of target-based antineoplastic agents, INV NEW DR, 18(1), 2000, pp. 7-16
Authors:
Ryan, CW
Vogelzang, NJ
Dumas, MC
Kuzel, T
Stadler, WM
Citation: Cw. Ryan et al., Granulocyte-macrophage-colony stimulating factor in combination immunotherapy for patients with metastatic renal cell carcinoma - Results of two phase II clinical trials, CANCER, 88(6), 2000, pp. 1317-1324
Authors:
Bigelow, KR
Spiotto, MT
Stadler, WM
Citation: Kr. Bigelow et al., Antiangiogenic agents and strategies in renal cell carcinoma, CUR CLIN ON, 4, 2000, pp. 381-395
Authors:
Stadler, WM
Kuzel, T
Shapiro, C
Sosman, J
Clark, J
Vogelzang, NJ
Citation: Wm. Stadler et al., Multi-institutional study of the angiogenesis inhibitor TNP-470 in metastatic renal carcinoma, J CL ONCOL, 17(8), 1999, pp. 2541-2545
Authors:
Chien, M
Astumian, M
Liebowitz, D
Rinker-Schaeffer, C
Stadler, WM
Citation: M. Chien et al., In vitro evaluation of flavopiridol, a novel cell cycle inhibitor, in bladder cancer, CANC CHEMOT, 44(1), 1999, pp. 81-87
Authors:
Beck, TP
Kirsh, EJ
Chmura, SJ
Kovar, DA
Chung, T
Rinker-Schaeffer, CW
Stadler, WM
Citation: Tp. Beck et al., In vitro evaluation of calphostin C as a novel agent for photodynamic therapy of bladder cancer, UROLOGY, 54(3), 1999, pp. 573-577
Authors:
Vogelzang, NJ
Stadler, WM
Citation: Nj. Vogelzang et Wm. Stadler, Gemcitabine and other new chemotherapeutic agents for the treatment of metastatic bladder cancer, UROLOGY, 53(2), 1999, pp. 243-250
Authors:
Yoshida, BA
Dubauskas, Z
Chekmareva, MA
Christiano, TR
Stadler, WM
Rinker-Schaeffer, CW
Citation: Ba. Yoshida et al., Mitogen-activated protein kinase kinase 4/stress-activated protein/Erk kinase 1 (MKK4/SEK1), a prostate cancer metastasis suppressor gene encoded by human chromosome 17, CANCER RES, 59(21), 1999, pp. 5483-5487
Authors:
Stadler, WM
Brendler, CB
Citation: Wm. Stadler et Cb. Brendler, The biology of bladder cancer, OX MED PUBL, 1999, pp. 141-156
Risultati:
1-24
|